Fineotex Chemical · NSE: FCL · BSE: 533333
Q4 FY25 results · Jan–Mar 2025
Fineotex Chemical reported revenue from operations of ₹119.79 crore (down 21.7% from Q4 FY24) and net profit of ₹20.13 crore (down 33.9% from Q4 FY24) for Q4 FY25 (Jan–Mar 2025), on a consolidated basis.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 119.79 | 153.02 | −21.7% | 125.92 | −4.9% |
| Other income | 7.55 | 4.15 | +82.0% | 4.99 | +51.3% |
| Total income | 127.33 | 157.16 | −19.0% | 130.91 | −2.7% |
| Profit before tax | 26.42 | 40.00 | −34.0% | 36.48 | −27.6% |
| Net profit for the period | 20.13 | 30.48 | −33.9% | 27.83 | −27.7% |
| Attributable to shareholders of the company | 19.97 | 30.11 | −33.7% | 27.63 | −27.7% |
| EPS, basic (₹) | 1.76 | 2.72 | −35.3% | 2.43 | −27.6% |
| Net margin (%) | 16.8 | 19.9 | 22.1 |
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 107.95 | 118.47 | −8.9% | 109.31 | −1.2% |
| Other income | 7.65 | 13.52 | −43.4% | 4.53 | +68.8% |
| Total income | 115.60 | 131.99 | −12.4% | 113.84 | +1.5% |
| Profit before tax | 25.73 | 40.70 | −36.8% | 32.11 | −19.9% |
| Net profit for the period | 19.44 | 32.89 | −40.9% | 24.49 | −20.6% |
| EPS, basic (₹) | 1.71 | 2.97 | −42.4% | 2.16 | −20.8% |
| Net margin (%) | 18.0 | 27.8 | 22.4 |
Consolidated
- Filed with BSE
- 20 May 2025, 22:42 IST
- Board meeting
- 20 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 20 May 2025, 22:42 IST
- Board meeting
- 20 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE